KEPHAS PHARMA
ActiveSummary
KEPHAS PHARMA has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €33,505 and a net result of €7,346. Its solvency ranks better than 72% of 25,599 sector peers (NACE 47, financial year 2024). The computed 12-month bankruptcy probability is 1.4% (low).
Directors
Directors
No directors read yet: 0 of 1 Gazette act processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.